KZIA
Kazia Therapeutics
$12.21
−$0.05 (−0.41%)Jul 27, 2026
Key metrics
The numbers that frame KZIA today
- Market cap
- $692.06M
- P/E (TTM)
- -42.8
- EV / FCF
- -63.9
- Gross margin
- 100%
- EV / Sales
- 484.9
- ROIC
- 207.8%
- Div yield
- 0%
- Debt / equity
- 0.3
- 52wk Low
- $4.86
- 52wk High
- $17.40
Growth
Revenue and earnings trend for KZIA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about KZIA
Is Kazia Therapeutics a good buy?
Hold. Kazia Therapeutics has excellent momentum, but poor quality makes the setup mixed. We think Kazia Therapeutics is selling at a high price.
What is the market capitalization of KZIA?
Kazia Therapeutics's market capitalization is $692.06M.
What is the P/E ratio for KZIA stock?
Kazia Therapeutics's current P/E ratio is -42.8.
What is the 52-week high for KZIA stock?
The 52-week high for Kazia Therapeutics is $17.40. The current close of $12.21 is 29.8% below that high.
What is the 52-week low for KZIA stock?
The 52-week low for Kazia Therapeutics is $4.86. The current close of $12.21 is 151.2% above that low.
Does KZIA stock pay dividends?
Kazia Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for KZIA?
Kazia Therapeutics's Debt / Equity ratio is 0.31.